日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Study of (131)I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

(131)I-间碘苄胍联合Dinutuximab±Vorinostat治疗复发或难治性神经母细胞瘤患者的I期研究:神经母细胞瘤治疗新方法试验

Cash Thomas, Marachelian Araz, DuBois Steven G, Chi Yueh-Yun, Baregamyan Anahit, Groshen Susan G, Jonus Hunter C, Shamirian Anasheh, Crowley Mary, Goodarzian Fariba, Acharya Patricia T, Pawel Bruce, Erbe Amy K, Shahi Ankita, Zaborek Jen, Kennedy Eleanor, Asgharzadeh Shahab, Villablanca Judith G, Pinto Navin, Weiss Brian D, Mosse Yael P, Desai Ami V, Macy Margaret E, Granger Meaghan, Vo Kieuhoa T, Sondel Paul M, Matthay Katherine K, Park Julie R, Goldsmith Kelly C

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, and Other Round Cell Sarcomas

尤文氏肉瘤、促纤维增生性小圆细胞肿瘤和其他圆细胞肉瘤

Underdown, M Jane; Kappa, Sarah; Metts, Jonathan; Cash, Thomas

Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE

新冠疫情爆发对儿科肿瘤医护人员和研究人员早期职业生涯的影响:来自儿童肿瘤协作组青年研究者委员会、国际儿科肿瘤学会青年网络和国际儿科肿瘤学会青年分会的报告

Bryan, Gemma; Guolla, Louise; Villanueva, Gabriela Inés; Cohen-Gogo, Sarah; Casanovas, Alejandra; Medina, Rina; Revon-Riviere, Gabriel; Coltin, Hallie; Kahalley, Lisa S; Withycombe, Janice S; van Ewijk, Roelof; Schoot, Reineke A; Cash, Thomas; Baertschiger, Reto M; McAleer, Mary Frances; Benedetti, Daniel J; Greengard, Emily; Kitko, Carrie L; Green, Adam L; Dhall, Girish; Esbenshade, Adam J

Fundamentals of Pediatric Cancer: How Pediatric Pathology and Infrastructure of Clinical Trials Impact Contemporary Interventional Oncology in Children

儿童癌症基础:儿科病理学和临床试验基础设施如何影响当代儿童介入肿瘤学

Mitchell, Sarah G; Sutton, Kathryn S; Cash, Thomas

Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031

儿童肿瘤协作组 AEWS0031 研究:接受间隔压缩化疗治疗的局限性尤文氏肉瘤患者的长期疗效

Cash, Thomas; Krailo, Mark D; Buxton, Allen B; Pawel, Bruce R; Healey, John H; Binitie, Odion; Marcus, Karen J; Grier, Holcombe E; Grohar, Patrick J; Reed, Damon R; Weiss, Aaron R; Gorlick, Richard; Janeway, Katherine A; DuBois, Steven G; Womer, Richard B

A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors

一项针对复发和/或难治性实体瘤和中枢神经系统肿瘤患儿的辛伐他汀联合拓扑替康和环磷酰胺的1期研究

Cash, Thomas; Jonus, Hunter C; Tsvetkova, Maya; Beumer, Jan H; Sadanand, Arhanti; Lee, Jasmine Y; Henry, Curtis J; Aguilera, Dolly; Harvey, R Donald; Goldsmith, Kelly C

Children's Oncology Group's 2023 blueprint for research: Young investigators

儿童肿瘤协作组2023年研究蓝图:青年研究人员

Esbenshade, Adam J; Kahalley, Lisa S; Wistinghausen, Birte; Cash, Thomas; Baertschiger, Reto M; Zarnegar-Lumley, Sara; Green, Adam; Dhall, Girish

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

恩曲替尼用于治疗携带 NTRK、ROS1 或 ALK 异常的实体瘤或原发性中枢神经系统肿瘤的儿童和青少年(STARTRK-NG)

Desai, Ami V; Robinson, Giles W; Gauvain, Karen; Basu, Ellen M; Macy, Margaret E; Maese, Luke; Whipple, Nicholas S; Sabnis, Amit J; Foster, Jennifer H; Shusterman, Suzanne; Yoon, Janet; Weiss, Brian D; Abdelbaki, Mohamed S; Armstrong, Amy E; Cash, Thomas; Pratilas, Christine A; Corradini, Nadège; Marshall, Lynley V; Farid-Kapadia, Mufiza; Chohan, Saibah; Devlin, Clare; Meneses-Lorente, Georgina; Cardenas, Alison; Hutchinson, Katherine E; Bergthold, Guillaume; Caron, Hubert; Chow Maneval, Edna; Gajjar, Amar; Fox, Elizabeth

Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia

患有急性淋巴细胞白血病/淋巴瘤且无严重中性粒细胞减少症的患儿在接受发热评估期间发生感染事件

Patel, Pratik A; DeGroote, Nicholas P; Jackson, Kasey; Cash, Thomas; Castellino, Sharon M; Jaggi, Preeti; Esbenshade, Adam J; Miller, Tamara P

A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response

跨越困境的桥梁——延长诱导治疗对诱导治疗结束时疗效不佳的高危神经母细胞瘤患者的治疗时间。

Federico, Sara M; Cash, Thomas